Innova Captab Limited announced the outcome of its board meeting held on August 21, 2026. The board approved revised audited financial results for the fiscal year ended March 31, 2026, along with a declaration of unmodified audit opinion. Additionally, the company’s board has sanctioned a brownfield expansion of its manufacturing facility in Baddi, Himachal Pradesh, involving an investment of approximately ₹45 crore.
Revised Financial Results Approved
Innova Captab Limited has officially released its revised audited financial results for the quarter and year ended March 31, 2026. The company’s board convened on August 21, 2026, to approve these revisions, which stem from identified inadvertent errors in the previously reported financials. An accompanying declaration from the Chief Financial Officer confirms an unmodified audit opinion on these revised results.
Manufacturing Facility Expansion in Baddi
Further strengthening its operational capabilities, the Board of Directors has also approved a significant brownfield expansion of the existing manufacturing facility located at Baddi, Himachal Pradesh. This expansion will add 2 Oral Solid Dosage (Tablets/Capsules) Production Lines to the existing setup, which currently includes 2 Oral Solid Dosage and 1 Ointment production line.
Project Details:
- Proposed Capacity Addition: 2 Oral Solid Dosage (Tablets/Capsules) Production Lines.
- Timeline: Expected completion within approximately 18 to 22 months.
- Investment: Approximately ₹45,00,00,000 (Rupees Forty Five Crore)
- Financing: A combination of bank credit facilities and the company’s internal accruals.
- Rationale: The expansion aims to increase production capacity, improve operational efficiency, optimize manufacturing costs, and support the company’s long-term growth and business expansion strategy.
The company’s revised consolidated financial results will be made available on its website, www.innovacaptab.com, and the stock exchanges.
Source: BSE
